financetom
Business
financetom
/
Business
/
Vuzix Ships Smart Glasses to Evantek Under New Order for Asia Pacific Region -- Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vuzix Ships Smart Glasses to Evantek Under New Order for Asia Pacific Region -- Shares Rise
Jan 21, 2025 9:37 AM

12:15 PM EST, 01/21/2025 (MT Newswires) -- Vuzix ( VUZI ) said Tuesday that it has shipped an initial order for its Vuzix M400 smart glasses from Evantek, a technology solutions provider, under a new distribution agreement.

Evantek will distribute Vuzix ( VUZI ) products to customers across the Asia Pacific region. Evantek plans to target sectors such as health care, field services, and manufacturing with Vuzix M400 smart glasses, the company added.

The financial details of the deal were not given.

Vuzix ( VUZI ) stock rose nearly 20% in recent trading activity.

Price: 3.66, Change: +0.60, Percent Change: +19.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Costco Q2 Earnings: Revenue Beat, EPS Miss, Comps Up 6.8% Driven By Strength In The US (CORRECTED)
Costco Q2 Earnings: Revenue Beat, EPS Miss, Comps Up 6.8% Driven By Strength In The US (CORRECTED)
Mar 7, 2025
Editor’s Note: This article has been updated to correct Costco’s reported second-quarter revenue. Costco Wholesale Corp ( COST ) reported financial results for the second quarter after the market close on Thursday. Here’s a rundown of the report. Q2 Earnings: Costco reported second-quarter revenue of $63.72 billion, beating the consensus estimate of $63.13 billion. The membership-based retailer reported second-quarter adjusted earnings of...
Plus Therapeutics' Brain Cancer Therapy Shows Promise in Early-Stage Study; Shares Rise
Plus Therapeutics' Brain Cancer Therapy Shows Promise in Early-Stage Study; Shares Rise
Mar 7, 2025
08:15 AM EST, 03/07/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Friday that its experimental drug, rhenium obisbemeda, demonstrated a median overall survival of 11 months in an early-stage study, outperforming the standard of care of 8 months for recurrent glioblastoma, a type of brain tumor. The clinical-stage company said that the study showed no dose-limiting toxicity, and...
US Treasury chief says plan to be put in place on acquiring crypto
US Treasury chief says plan to be put in place on acquiring crypto
Mar 7, 2025
WASHINGTON (Reuters) - Plans will be discussed about how to acquire cryptocurrency for a U.S. strategic reserve that will include bitcoin, Treasury Secretary Scott Bessent told CNBC on Friday before industry leaders meet with President Donald Trump at the White House. Bessent, in an interview, said seized crypto assets would go into the reserve first then we'll see what the...
Trulieve Appoints Ryan Blust as Chief Financial Officer
Trulieve Appoints Ryan Blust as Chief Financial Officer
Mar 7, 2025
08:15 AM EST, 03/07/2025 (MT Newswires) -- Trulieve Cannabis ( TCNNF ) on Friday said it has appointed Ryan Blust as chief financial officer. He takes over from Wes Getman who has departed to pursue other opportunities. Blust is Trulieve's vice president, Finance. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved